Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
GLP-1 receptor agonists such as semaglutide (marketed under brand names Ozempic, Wegovy, and Rybelsus) and the dual GIP/GLP-1 agonist tirzepatide (marketed under brand names Mounjaro and Zepbound) are FDA-approved prescription medications for specific uses in type 2 diabetes management and, in some cases, chronic weight management
Related Products Our most selling products
doi: 10.1186/s12866-019-1399-5 178 SchnellA.HuangL.SingerM.SingarajuA.BarillaR
GLP-1s show promise in reducing nerve inflammation and cell death while supporting nerve health
Individuals with metabolic syndrome features that span multiple domains (visceral obesity, insulin resistance, dyslipidemia) who want comprehensive metabolic intervention
Common Degradation Pathways Deamidation of asparagine residues Methionine oxidation Peptide backbone hydrolysis Acyl chain hydrolysis Isomerization reactions Advanced LC-MS methods allow researchers to identify the exact location of degradation events within the peptide sequence
